Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$9.81 - $15.4 $92,704 - $145,530
-9,450 Reduced 4.33%
208,808 $2.27 Million
Q4 2021

Feb 14, 2022

BUY
$12.09 - $14.68 $2.64 Million - $3.2 Million
218,258 New
218,258 $2.95 Million
Q3 2021

Oct 27, 2021

SELL
$13.25 - $15.13 $12.1 Million - $13.8 Million
-910,632 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$12.97 - $16.15 $470,395 - $585,728
-36,268 Reduced 3.83%
910,632 $13 Million
Q1 2021

May 11, 2021

BUY
$13.59 - $18.54 $4.98 Million - $6.79 Million
366,407 Added 63.12%
946,900 $13.2 Million
Q4 2020

Feb 03, 2021

BUY
$14.3 - $18.74 $8.3 Million - $10.9 Million
580,493 New
580,493 $10.9 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Jabodon Pt CO Portfolio

Follow Jabodon Pt CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jabodon Pt CO, based on Form 13F filings with the SEC.

News

Stay updated on Jabodon Pt CO with notifications on news.